Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

CCCC · Insider trading · 13F holders · Congress trades

C4 Therapeutics, Inc. (CCCC)

Who is buying and selling CCCC: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
15
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

CCCC at a glance

  • No open-market insider purchases or sales of CCCC were filed in the last 90 days.
  • 15 13F filers hold CCCC among their 50 largest positions, worth $199.0M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Squadron Capital Management LLC (11.5%), Lynx1 Capital Management LP (4.0%) and Bain Capital Life Sciences Investors, LLC (2.0%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.
  • No member of Congress has disclosed a trade in CCCC.

CCCC insider trading

No open-market insider purchases or sales of CCCC were filed in the last 90 days.

Who owns CCCC? Hedge funds and superinvestors

15 13F filers hold CCCC among their 50 largest positions, worth $199.0M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Squadron Capital Management LLC (11.5%), Lynx1 Capital Management LP (4.0%) and Bain Capital Life Sciences Investors, LLC (2.0%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.

Superinvestors holding CCCC: Peter Kolchinsky 0.3%

13F filers holding CCCC
Manager% of portfolioValueSharesLast quarter13F
Peter KolchinskyHedge fund0.3%$37.4M8,000,000—Q2 2026
Lynx1 Capital Management LPHedge fund4.0%$34.2M7,326,691+4.7% sharesQ2 2026
Squadron Capital Management LLCHedge fund11.5%$33.6M7,200,000+220.0% sharesQ2 2026
Bain Capital Life Sciences Investors, LLCAsset manager2.0%$33.5M7,171,910+0.0% sharesQ2 2026
Soleus Capital Management, L.P.Hedge fund0.5%$15.8M3,377,981-11.2% sharesQ2 2026
Silverarc Capital Management, LLCHedge fund1.6%$14.2M3,032,060+58.6% sharesQ2 2026
Ikarian Capital, LLCHedge fund1.9%$11.4M2,433,000—Q2 2026
Patient Square Capital LPHedge fund1.2%$7.5M1,608,815NewQ2 2026
HighVista Strategies LLCHedge fund1.4%$6.3M1,348,136—Q2 2026
Velan Capital Investment Management LPHedge fund1.6%$2.7M570,000NewQ2 2026
Seven Fleet Capital Management LPHedge fund0.3%$1.8M381,169—Q2 2026
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance GroupInsurance company0.1%$397K85,000+0.0% sharesQ2 2026
Intrepid Family Office LLCFamily office0.3%$304K65,000+8.3% sharesQ2 2026
Bronte Capital Management Pty Ltd.Hedge fund0.0%$48K10,349+3.1% sharesQ2 2026
CDC Financial, Inc.Investment manager0.0%$5K1,000NewQ2 2026

Each manager counts with its latest 13F (Q2 2026: 15). Screen CCCC in the grand portfolio →

CCCC stock trades by members of Congress

No member of Congress has disclosed a trade in CCCC.

CCCC questions and answers

Are insiders buying CCCC stock?

No open-market insider purchases or sales of CCCC were filed in the last 90 days.

Which hedge funds own CCCC?

15 13F filers hold CCCC among their 50 largest positions, worth $199.0M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Squadron Capital Management LLC (11.5%), Lynx1 Capital Management LP (4.0%) and Bain Capital Life Sciences Investors, LLC (2.0%). In their latest 13Fs, 3 managers opened a new position and 3 added to one.

Has Congress traded CCCC?

No member of Congress has disclosed a trade in CCCC.

Who is the largest holder of CCCC?

Among 13F filers, Peter Kolchinsky reports the largest CCCC position, $37.4M (8,000,000 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Squadron Capital Management LLC's: 11.5% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link